Abstract
Purpose
The purpose of our
study is to investigate the delay in diagnosis of patients with
biopsy-proven celiac disease in those who present with
gastrointestinal complaints vs nongastrointestinal complaints at our
tertiary care center. Celiac disease is an autoimmune disorder that
affects approximately 1% of the population worldwide. Celiac disease
can have variable clinical presentations; it can be characterized by
predominately gastrointestinal symptoms, or it may present without
any gastrointestinal symptoms.
Methods
We retrospectively
reviewed the charts of 687 adult patients who carried the diagnosis
of celiac disease. Patients included had biopsy-proven celiac disease
and were categorized based on presence or absence of gastrointestinal
symptoms prior to their diagnosis.
Results
There were 101
patients with biopsy-proven celiac disease that met inclusion
criteria. Fifty-two patients presented with gastrointestinal symptoms
and 49 had nongastrointestinal complaints. Results from Mann-Whitney
statistical analysis showed a median delay in diagnosis of 2.3 months
for the gastrointestinal symptoms group and 42 months for the
nongastrointestinal group (P less than .001); 43.2% of patients with
nongastrointestinal symptoms had abnormal thyroid-stimulating
hormone, as opposed to 15.5% in the gastrointestinal symptom group (P
= .004). Of patients with nongastrointestinal symptoms, 69.4% had
anemia, compared with 11.5% of the gastrointestinal symptom group (P
less than .001). The majority of patients in the nongastrointestinal
symptom group, 68%, were noted to have abnormal bone density scans,
compared with 41% in the gastrointestinal symptom group. No sex
differences were noted on chi-squared analysis between the 2 groups
(P = .997).
Conclusions
Although there is
growing awareness of celiac disease, the delay in diagnosis for
patients without gastrointestinal symptoms remains prolonged, with an
average delay of 3.5 years.
Clinical
Significance
There is a mean
delay in the diagnosis of celiac disease of 3.5 years in patients who
present with nongastrointestinal symptoms.
Specifically,
patients with thyroid abnormalities, anemia, or bone mineral density
loss should be screened for celiac disease.
Celiac disease is an
autoimmune disorder that affects approximately 1% of the population
worldwide.1 As many as 6 of 7 cases of celiac disease remain
undiagnosed.2 This discrepancy falls in line with the widely accepted
“celiac iceberg” concept and may be due to the fact that patients
have variable presentations of celiac disease. Manifestations of
celiac disease range from typical gastrointestinal complaints
characterized by malabsorption and diarrhea, to more silent forms in
patients without overt gastrointestinal complaints.
Nongastrointestinal presentations may include anemia, thyroid
dysfunction, osteoporosis, liver function test abnormalities, and
skin manifestations such as dermatitis herpetiformis. The variable
presentations create a clinical challenge to physicians in reaching
an early diagnosis. As a result, delay in diagnosis is not uncommon
and does not go without consequence. Undiagnosed celiac disease can
lead to osteoporotic fractures, infertility, unnecessary surgical
procedures including bowel resection, and malignancy.1 As the
majority of cases of celiac disease can be treated with a strict
gluten-free diet alone, adherence to this diet can reverse the risk
for adverse clinical outcomes.
No comments:
Post a Comment